C5H9NO2
Neat
115.13
183805-10-9; N-[(2S)oxiranylmethyl]acetamide; Acetamide, N-[(2S)-oxiranylmethyl]-; N-[[(2S)-oxiran-2-yl]methyl]acetamide; (S)-N-(Oxiran-2-ylmethyl)acetamide; (S)-(+)-N-(oxiranylMethyl)acetaMide; N-{[(2S)-oxiran-2-yl]methyl}acetamide; Linezolid Impurity 33; QF9L2VVS9S; (S)-N-oxiranylmethyl-acetamide; SCHEMBL2863034; N-((S)-Oxiranylmethyl)acetamide; DTXSID80453297; HBTVZPMDLRPWKZ-YFKPBYRVSA-N; N-[(2S)oxiranylmethyl] acetamide; N-[(2S)-2-Oxiranylmethyl]acetamide; Acetamide, N-(oxiranylmethyl)-, (S)-; Acetamide and N-[(2S)-2-oxiranylmethyl]-; CS-0166034; (S)-N-(oxiran-2-ylmethyl)acetamide? (Brexpiprazole Impurity pound(c)
N-[[(2S)-oxiran-2-yl]methyl]acetamide
InChI=1S/C5H9NO2/c1-4(7)6-2-5-3-8-5/h5H,2-3H2,1H3,(H,6,7)/t5-/m0/s1